文献速递心力衰竭与心肌病冠心病

PHF7表观遗传重编程改善小鼠心肌梗死后心脏功能

Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction.
PubMed 文献 · Circulation · 2025-07-09

本研究在小鼠心肌梗死模型中递送表观遗传因子PHF7,通过成纤维细胞谱系追踪和多组学分析,发现单因子PHF7可在体内诱导成纤维细胞向心肌细胞重编程,并改善急性和慢性心力衰竭的心脏功能与重构,单因子递送可改善生存、功能和纤维化至损伤后16周。

要点

  • PHF7单因子可在小鼠梗死心脏诱导成纤维细胞向心肌细胞重编程。
  • PHF7递送改善急性与慢性心衰模型的心脏功能和重构。
  • 单因子PHF7改善梗死小鼠生存、功能和纤维化至16周。

核心结论

  • 单表观遗传因子PHF7可在小鼠心肌梗死后诱导重编程并改善心脏功能。

研究设计与样本

  • 研究采用体外实验结合全基因组研究,并在小鼠心肌梗死模型中经心肌内递送逆转录病毒PHF7鸡尾酒,结合遗传成纤维细胞谱系追踪。
  • 体内应用10X多组学生成梗死心脏PHF7重编程的单核转录组与表观基因组联合图谱。

主要发现

  • 体外全基因组转录分析显示,在成纤维细胞中向Tbx5或Mef2c与Tbx5加入PHF7,通过上调独特心脏转录组诱导全局重编程。
  • PHF7在真皮成纤维细胞过表达时上调心脏主调控因子。
  • 向梗死小鼠心脏递送PHF7鸡尾酒诱导体内重编程事件,并改善急性和慢性心力衰竭的心脏功能与重构。
  • 单因子PHF7递送至梗死心脏改善生存、功能和纤维化至损伤后16周。
  • 遗传谱系追踪显示PHF7在体内诱导真正的成纤维细胞向心肌细胞重编程事件。

临床怎么用

  • PHF7作为单因子在梗死小鼠心脏中诱导重编程并恢复功能,支持表观遗传因子用于缺血性心脏病治疗的转化潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart disease. However, current reprogramming strategies require excessive factors due to epigenetic barriers of adult mouse and human fibroblasts. Recently, we identified the epigenetic factor PHF7 from a screen of gene-regulatory factors as the most potent activator of adult fibroblast-to-cardiomyocyte reprogramming in vitro. METHODS: Through in vitro assays coupled with genome-wide studies, we interrogated the ability of PHF7 to induce reprogramming events with minimal reprogramming factors. Using in vivo murine models of myocardial infarction and intramyocardial reprogramming factor delivery coupled with genetic fibroblast lineage tracing, we delivered retroviral PHF7 cocktails to the murine heart and interrogated reprogramming events as well as the acute and chronic functional impact of these cocktails. Deployment of 10X multiomics in vivo generated a combinatorial single-nucleus transcriptomic and epigenomic atlas of PHF7 reprogramming in the infarcted heart. RESULTS: Genome-wide in vitro transcriptomic analyses revealed that addition of PHF7 to Tbx5 or Mef2c and Tbx5 in fibroblasts induced global reprogramming through upregulation of unique cardiac transcriptomes. Further, PHF7 itself upregulated cardiac master regulators when overexpressed in dermal fibroblasts. Delivery of PHF7 cocktails to the infarcted murine heart induced in vivo reprogramming events and improved cardiac function and remodeling in both acute and chronic heart failure. When delivered as a single factor to the infarcted heart, PHF7 improved survival, function, and fibrosis up to 16 weeks after injury. Genetic lineage tracing analyses revealed that PHF7 induced bona fide fibroblast-to-cardiomyocyte reprogramming events in vivo. Comprehensive multiomics of PHF7 cocktails in the infarcted heart exposed the impact of PHF7 on chromatin structure, generating population-level shifts in nonmyocyte and cardiomyocyte cellular identity. CONCLUSIONS: Here, we report the ability of a single epigenetic factor, PHF7, to induce reprogramming and improve cardiac function in the mouse heart following myocardial infarction. Together, these data support the premise that a single factor, when deployed into the infarcted mouse heart, can induce reprogramming events and recover function in the ischemic heart.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Bann, Dos Santos, Chen, et al. Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction. Circulation. 2025. PMID: 40631661. doi:10.1161/CIRCULATIONAHA.124.072733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。